Back to Index
Maria Teresa Ochoa, MD
Associate Professor of Clinical Dermatology
HC4 2000 1450 San Pablo Health Sciences Campus Los Angeles
+1 323 442 6200


IL-27 Suppresses Antimicrobial Activity in Human Leprosy. J Invest Dermatol. 2015 Jun 1. View in: PubMed

T lymphocyte density and distribution in human colorectal mucosa, and inefficiency of current cell isolation protocols. PLoS One. 2015; 10(4):e0122723. View in: PubMed

Recognizing and managing the immunologic reactions in leprosy. J Am Acad Dermatol. 2014 Oct; 71(4):795-803. View in: PubMed

Antigen-Presenting Cell Candidates for HIV-1 Transmission in Human Distal Colonic Mucosa Defined by CD207 Dendritic Cells and CD209 Macrophages. AIDS Res Hum Retroviruses. 2014 Mar; 30(3):241-9. View in: PubMed

NOD2 triggers an interleukin-32-dependent human dendritic cell program in leprosy. Nat Med. 2012 Apr; 18(4):555-63. View in: PubMed

Mobile teledermatology: As doctors and patients are increasingly mobile, technology keeps us connected. Skinmed. 2011 Jul-Aug; 9(4):231-8. View in: PubMed

New World cutaneous leishmaniasis: current challenges in diagnosis and parenteral treatment. J Am Acad Dermatol. 2011 Mar; 64(3):587-92. View in: PubMed

Interleukin-4 regulates the expression of CD209 and subsequent uptake of Mycobacterium leprae by Schwann cells in human leprosy. Infect Immun. 2010 Nov; 78(11):4634-43. View in: PubMed

A role for interleukin-5 in promoting increased immunoglobulin M at the site of disease in leprosy. Immunology. 2010 Nov; 131(3):405-14. View in: PubMed

Human immunodeficiency virus and leishmaniasis. J Glob Infect Dis. 2010 Sep; 2(3):248-57. View in: PubMed

Integrated pathways for neutrophil recruitment and inflammation in leprosy. J Infect Dis. 2010 Feb 15; 201(4):558-69. View in: PubMed

Divergence of macrophage phagocytic and antimicrobial programs in leprosy. Cell Host Microbe. 2009 Oct 22; 6(4):343-53. View in: PubMed

Dendritic cell vaccination combined with CTLA4 blockade in patients with metastatic melanoma. Clin Cancer Res. 2009 Oct 1; 15(19):6267-76. View in: PubMed

"Dermal dendritic cells" comprise two distinct populations: CD1+ dendritic cells and CD209+ macrophages. J Invest Dermatol. 2008 Sep; 128(9):2225-31. View in: PubMed

Host-derived oxidized phospholipids and HDL regulate innate immunity in human leprosy. J Clin Invest. 2008 Aug; 118(8):2917-28. View in: PubMed

LILRA2 activation inhibits dendritic cell differentiation and antigen presentation to T cells. J Immunol. 2007 Dec 15; 179(12):8128-36. View in: PubMed

Activation of human CD4+ T cells by targeting MHC class II epitopes to endosomal compartments using human CD1 tail sequences. Immunology. 2007 Dec; 122(4):522-31. View in: PubMed

Regulation of human T-cell homing receptor expression in cutaneous bacterial infection. Immunology. 2007 Apr; 120(4):518-25. View in: PubMed

Functional characterization of a T-cell receptor BV6+ T-cell clone derived from a leprosy lesion. Immunology. 2007 Mar; 120(3):354-61. View in: PubMed

Macrophages acquire neutrophil granules for antimicrobial activity against intracellular pathogens. J Immunol. 2006 Aug 1; 177(3):1864-71. View in: PubMed

TLR activation of Langerhans cell-like dendritic cells triggers an antiviral immune response. J Immunol. 2006 Jul 1; 177(1):298-305. View in: PubMed

Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006 Mar 24; 311(5768):1770-3. View in: PubMed

Human dendritic cell expression of HLA-DO is subset specific and regulated by maturation. J Immunol. 2006 Mar 15; 176(6):3536-47. View in: PubMed

TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells. Nat Med. 2005 Jun; 11(6):653-60. View in: PubMed

Mohs' micrographic surgery of a proliferating trichilemmal tumor in a young black man. Dermatol Surg. 2005 Mar; 31(3):359-63. View in: PubMed

Langerhans cells utilize CD1a and langerin to efficiently present nonpeptide antigens to T cells. J Clin Invest. 2004 Mar; 113(5):701-8. View in: PubMed

Use of genetic profiling in leprosy to discriminate clinical forms of the disease. Science. 2003 Sep 12; 301(5639):1527-30. View in: PubMed

Activation and regulation of Toll-like receptors 2 and 1 in human leprosy. Nat Med. 2003 May; 9(5):525-32. View in: PubMed

Expression of Toll-like receptor 2 on human Schwann cells: a mechanism of nerve damage in leprosy. Infect Immun. 2003 Mar; 71(3):1427-33. View in: PubMed

Distribution of Toll-like receptor 1 and Toll-like receptor 2 in human lymphoid tissue. Immunology. 2003 Jan; 108(1):10-5. View in: PubMed

Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. J Immunol. 2002 Aug 1; 169(3):1535-41. View in: PubMed

Signaling lymphocytic activation molecule expression and regulation in human intracellular infection correlate with Th1 cytokine patterns. J Immunol. 2001 Nov 15; 167(10):5719-24. View in: PubMed

Treatment failure in children in a randomized clinical trial with 10 and 20 days of meglumine antimonate for cutaneous leishmaniasis due to Leishmania viannia species. Am J Trop Med Hyg. 2001 Mar-Apr; 64(3-4):187-93. View in: PubMed

Induction of direct antimicrobial activity through mammalian toll-like receptors. Science. 2001 Feb 23; 291(5508):1544-7. View in: PubMed

T-cell release of granulysin contributes to host defense in leprosy. Nat Med. 2001 Feb; 7(2):174-9. View in: PubMed

Role of granulysin in immunity to leprosy. Lepr Rev. 2000 Dec; 71 Suppl:S115; discussion S115-6. View in: PubMed

Activation of toll-like receptor 2 on human dendritic cells triggers induction of IL-12, but not IL-10. J Immunol. 2000 Oct 1; 165(7):3804-10. View in: PubMed

Evidence for human CD4+ T cells in the CD1-restricted repertoire: derivation of mycobacteria-reactive T cells from leprosy lesions. J Immunol. 2000 May 1; 164(9):4790-6. View in: PubMed

Positive IgG Western blot for Borrelia burgdorferi in Colombia. Mem Inst Oswaldo Cruz. 1999 Jul-Aug; 94(4):499-503. View in: PubMed

IL-18 promotes type 1 cytokine production from NK cells and T cells in human intracellular infection. J Immunol. 1999 May 15; 162(10):6114-21. View in: PubMed

Mucosal leishmaniasis due to Leishmania (Viannia) panamensis in Colombia: clinical characteristics. Am J Trop Med Hyg. 1998 Jul; 59(1):49-52. View in: PubMed

Treatment of cutaneous leishmaniasis in Colombia with dapsone. Lancet. 1998 Feb 14; 351(9101):498-9. View in: PubMed

Changes in expression of signal transduction proteins in T lymphocytes of patients with leprosy. Infect Immun. 1998 Feb; 66(2):499-504. View in: PubMed

Lepromatous and tuberculoid leprosy: clinical presentation and cytokine responses. Int J Dermatol. 1996 Nov; 35(11):786-90. View in: PubMed

A yeast-derived antigen from Paracoccidioides brasiliensis useful for serologic testing. Sabouraudia. 1985 Feb; 23(1):23-9. View in: PubMed

Powered bySC CTSI